Antibody-Based Therapies for Emerging Infectious Diseases
Open Access
- 1 September 1996
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 2 (3) , 200-208
- https://doi.org/10.3201/eid0203.960306
Abstract
Volume 22, Number 7—July 2016 - Emerging Infectious Disease journal - CDCThis publication has 71 references indexed in Scilit:
- Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacyAntimicrobial Agents and Chemotherapy, 1995
- Antimicrobial resistance in Streptococcus pneumoniae: can immunization prevent its spread?1994
- Infectious Disease Surveillance: a Crumbling FoundationScience, 1994
- Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.The Journal of Immunology, 1993
- Adoptive immunotherapy of Gram-negative sepsisCritical Care Medicine, 1993
- Humanised monoclonal antibody therapy for rheumatoid arthritisThe Lancet, 1992
- Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization.The Journal of Experimental Medicine, 1992
- Intracellular neutralization of virus by immunoglobulin A antibodies.Proceedings of the National Academy of Sciences, 1992
- Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicityInfection and Immunity, 1991
- Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier.Proceedings of the National Academy of Sciences, 1991